http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201605452-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dadd30411e66b8e97322e32c6eb9960e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10716a2696e89e91d90775f60f8fee2e |
| publicationDate | 2016-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201605452-A |
| titleOfInvention | a pharmaceutical composition containing a pyrimidine compound as an active ingredient |
| abstract | An object of the present invention is to provide a therapeutic pharmaceutical composition for cancer associated with FGFR4, cancer associated with FGF19, or liver cancer with positive FGF19 gene amplification.nThe solution of the present invention is to review a compound having an inhibitory effect on FGFR4, and to confirm that a specific pyrimidine compound has an inhibitory action against FGFR4, and a pharmaceutical composition containing the compound as an active ingredient, and a cancer associated with FGFR4, and other embodiments The cancer associated with FGF19 and the FGF19 gene amplification-positive liver cancer of another embodiment have therapeutic effects, and the present invention has been completed. |
| priorityDate | 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.